Printer Friendly

MINNTECH CORPORATION ANNOUNCES SLOWER GROWTH IN REVENUES

 MINNEAPOLIS, Oct. 11 /PRNewswire/ -- Minntech Corporation (NASDAQ: MNTX) announced today that revenues and earnings in the second quarter ended Sept. 30, 1993 will be slightly less than the first quarter's results and below analysts' expectations. The company further expects that revenue growth in the second half of the fiscal year will fall below the company's targeted growth rate.
 Dr. Louis C. Cosentino, president and chief executive officer, reported, "We are experiencing difficulty increasing revenues due primarily to significant and unreasonable regulatory delays by the FDA with respect to our new products. Our new product 510(k) applications have been on file with the FDA for 16 months without any review. In the past four months, the FDA has approved only two 510(k) submissions in a similar product category, and at this pace we have no reason to anticipate approval in the near future." Cosentino concluded, "The company is adjusting its operations commensurate with its revised revenue growth expectations."
 Minntech Corporation is a leading medical device manufacturer with advanced technology in electronics, solutions, fibers and plastics. The company's core technologies are being applied to the businesses of dialysis, reprocessing/sterilants, cardiosurgery and water purification. Minntech Corporation's common stock is traded on the National Over-The- Counter market under the NASDAQ symbol MNTX.
 -0- 10/11/93
 /CONTACT: Robert M. Rosner, executive vice president and treasurer of Minntech Corporation, 612-553-3300/
 (MNTX)


CO: Minntech Corporation ST: Minnesota IN: MTC SU: ERP

CP-DB -- MN009 -- 0718 10/11/93 13:35 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 11, 1993
Words:247
Previous Article:QMC ANNOUNCES FIRST QUARTER FISCAL 1994 FINANCIAL RESULTS
Next Article:DRUG SCREENING SYSTEMS REPORTS FOURTH QUARTER, 12 MONTHS RESULTS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters